Accessibility: Skip TopNav
Figure 2
Pepinemab treatment appears to slow Cognitive decline in Huntington’s disease (Huntington’s Disease Cognitive Assessment Battery)
Format
JPEG
Source
Vaccinex, Inc.
Downloads
Original
Large
Medium
Small